Reuters logo
BRIEF-Royalty Pharma increases offer to acquire Elan
June 7, 2013 / 10:41 AM / in 4 years

BRIEF-Royalty Pharma increases offer to acquire Elan

LONDON, June 7 (Reuters) - Royalty Pharma: * Royalty Pharma increases offer to acquire Elan * Increased offer, including CVR, potentially values Elan share at up to $15.50

if three CVR payment events occur * Offering upfront cash value of $4.9 billion for Tysabri royalty * Urges Elan stockholders to vote “ against all” items on the agenda at the

Elan EGM * Will waive down acceptance threshold to 50% plus one share if all other

conditions to increased offer satisfied * Offer to lapse if theravance resolution or any of the other resolutions

approved by Elan investors at Elan EGM * Source text for Eikon:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below